📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Correction: Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer. (2020)

First Author: Li S

Attributed to: BAG-1: A novel strategy for targeting the androgen receptor splice variants in castrate resistant prostate cancer. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/0008-5472.can-20-0768

PubMed Identifier: 32414837

Publication URI: http://europepmc.org/abstract/MED/32414837

Type: Journal Article/Review

Volume: 80

Parent Publication: Cancer research

Issue: 10

ISSN: 0008-5472